These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Methods of second trimester pregnancy termination and evacuation of in utero dead fetuses. Value of mifepristone]. Maria B; Matheron I J Gynecol Obstet Biol Reprod (Paris); 1994; 23(6):642-50. PubMed ID: 7995906 [TBL] [Abstract][Full Text] [Related]
3. Antiprogestins and the abortion controversy: a progress report. Klitsch M Fam Plann Perspect; 1991; 23(6):275-82. PubMed ID: 1786809 [TBL] [Abstract][Full Text] [Related]
4. Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implications. Bygdeman M; Gemzell K; Gottlieb C; Swahn ML Ann N Y Acad Sci; 1991; 626():561-7. PubMed ID: 2058973 [TBL] [Abstract][Full Text] [Related]
5. The combined use of prostaglandin and antiprogestin in human fertility control. Baulieu EE Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():55-62. PubMed ID: 7732905 [TBL] [Abstract][Full Text] [Related]
6. Approval of mifepristone (RU 486) in Europe. Sitruk-Ware R Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210 [TBL] [Abstract][Full Text] [Related]
7. Nongenomic uterine relaxing effect of RU 486 (mifepristone) prior to its antiprogesterone activity in the human pregnancy. Perusquía M; Espinoza J; Navarrete E Steroids; 2009 Oct; 74(10-11):825-31. PubMed ID: 19464306 [TBL] [Abstract][Full Text] [Related]
8. Mifepristone (RU 486). Med Lett Drugs Ther; 1990 Dec; 32(833):112-3. PubMed ID: 2247020 [TBL] [Abstract][Full Text] [Related]
9. [Termination of early pregnancy using RU 486 alone or in combination with prostaglandin. The RU 486 Collaboration Group]. Zhonghua Fu Chan Ke Za Zhi; 1990 Jan; 25(1):31-4, 62. PubMed ID: 2182310 [TBL] [Abstract][Full Text] [Related]
10. Medical management for termination of second and third trimester pregnancies: a comparison of strategies. De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361 [TBL] [Abstract][Full Text] [Related]
11. [RU 486 (mifepristone) and therapeutic abortions in the second and third trimesters]. Pons JC; Rais S; Diochin P; Frydman R J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):255-7. PubMed ID: 1583307 [TBL] [Abstract][Full Text] [Related]
12. Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure. Bos-Thompson MA; Hillaire-Buys D; Roux C; Faillie JL; Amram D Ann Pharmacother; 2008 Jun; 42(6):888-92. PubMed ID: 18460590 [TBL] [Abstract][Full Text] [Related]
13. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium. Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418 [TBL] [Abstract][Full Text] [Related]
14. Medical abortion in the second trimester. Tang OS; Ho PC Best Pract Res Clin Obstet Gynaecol; 2002 Apr; 16(2):237-46. PubMed ID: 12041965 [TBL] [Abstract][Full Text] [Related]
20. [The value of RU-486 (mifepristone) in medical indications of the induction of labor at term. Results of a double-blind randomized prospective study (RU-486 versus placebo)]. Lelaidier C; Benifla JL; Fernandez H; Baton C; Bourget P; Bourrier MC; Frydman R J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):91-100. PubMed ID: 8463575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]